Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100869205 | 10086920 | 5 | F | 20160831 | 20140418 | 20160908 | EXP | PHHY2014CA046475 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160908 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100869205 | 10086920 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, BID | 22068 | 400 | MG | CAPSULE | BID | ||||||
| 100869205 | 10086920 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | 300 MG, BID | 22068 | 300 | MG | CAPSULE | BID | ||||||
| 100869205 | 10086920 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | U | 0 | ||||||||||
| 100869205 | 10086920 | 4 | C | ELTROXIN | LEVOTHYROXINE | 1 | Unknown | U | 0 | ||||||||||
| 100869205 | 10086920 | 5 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | U | 0 | ||||||||||
| 100869205 | 10086920 | 6 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100869205 | 10086920 | 1 | Chronic myeloid leukaemia |
| 100869205 | 10086920 | 3 | Gastric ulcer |
| 100869205 | 10086920 | 4 | Product used for unknown indication |
| 100869205 | 10086920 | 5 | Product used for unknown indication |
| 100869205 | 10086920 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100869205 | 10086920 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100869205 | 10086920 | Alopecia | |
| 100869205 | 10086920 | Back pain | |
| 100869205 | 10086920 | Blood pressure increased | |
| 100869205 | 10086920 | Dry skin | |
| 100869205 | 10086920 | Dyspepsia | |
| 100869205 | 10086920 | Eructation | |
| 100869205 | 10086920 | Fatigue | |
| 100869205 | 10086920 | Incorrect dose administered | |
| 100869205 | 10086920 | Intestinal perforation | |
| 100869205 | 10086920 | Muscle spasms | |
| 100869205 | 10086920 | Pain | |
| 100869205 | 10086920 | Polyp | |
| 100869205 | 10086920 | Stress |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100869205 | 10086920 | 1 | 20140404 | 20140507 | 0 |